Skip to main content

RailTel Corporation of India files DRHP for Rs 700 crore IPO

RailTel is a a category 1 mini-ratna central public sector enterprise, wholly owned by the Government of India under the administrative control of the Ministry of Railways

State-owned RailTel Corporation of India, one of the largest neutral telecom infrastructure services providers, has filed its draft red herring prospectus (DRHP) with capital market regulator Sebi for its initial public offering on September 29.

Sources said the company is expected to raise approximately Rs 700 crore.

RailTel is a a category 1 mini-ratna central public sector enterprise, wholly owned by the Government of India under the administrative control of the Ministry of Railways.

As the objective of the issue is to disinvestment the government's stake, the company will not receive any proceeds from the offer.

The issue consists an offer for sale of 8,66,53,369 shares and employee reserved portion by the Government of India.

Incorporated in 2000, RailTel provides telecom network and infrastructure services, managed data centre and hosting services, and system integration services to government and non-government customers.

The company was incorporated with the aim of modernising the existing telecom system for train control, operation and safety, besides creating a nationwide broadband and multimedia network by laying optical fibre cable along the railway tracks.



As on June 30, its optic fibre network covers over 55,000 km and 5,677 railway stations across towns and cities in the country.

It has also been selected for implementation of various mission-mode projects for the government including rolling out the National Knowledge Network (NKN), Bharat Net and optical fibre-based connectivity project in northeast India. It also undertakes Information & Communication Technology (ICT) projects.

Its operations have been funded entirely by internal accruals since 2013 and it currently enjoys a debt free status. Revenue from operations grew at 7.47 percent compounded annual growth rate (CAGR) during FY18-20.

ICICI Securities, IDBI Capital and SBI Capital Markets are appointed as book running lead managers to the issue.

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more